[2] Structure, functional aspects, metabolism: May 12–14, 1982, Leiden, The Netherlands

Book

[2] Structure, functional aspects, metabolism

May 12–14, 1982, Leiden, The Netherlands

Edited by: F. Haverkate

Part of the multi-volume work

Fibrinogen. Proceedings/ Workshop on Fibrinogen

Language: German

Published/Copyright: 1983

Published by

Become an author with De Gruyter Brill

Explore this Subject How to publish with us

Topics

Frontmatter Publicly Available Download PDF	I
Preface Publicly Available Download PDF	V
Contributors And Addresses Publicly Available Download PDF	VII
Contents Publicly Available Download PDF	XIII
I. Physicochemical Aspects
Hydrodynamic characterization of human fibrinogen Alfons C.M. van der Drift, Aldi Poppema, Frits Haverkate and Willem Nieuwenhuizen Requires Authentication Unlicensed Licensed	3
Early plasmin digestion of fibrinogen: light scattering data G. Dietler, P. Wiltzius, P. Grolimund, W. Känzig, A. Häberli and P.W. Straub Requires Authentication Unlicensed Licensed	19
Correlation of fibrinopeptide A release and light scattering during fibrinogen to fibrin transformation P. Wiltzius, G. Dietler, W. Känzig, A. Häberli and P.W. Straub Requires Authentication Unlicensed Licensed	25
A kinetic approach to the polymerization of fibrin at high ionic strength A. Visser and T.A. Payens Requires Authentication Unlicensed Licensed	31
Secondary Structure Of Fibrin Gilbert Hudry-Clergeon, Jean Marx and Maurice Berjot Requires Authentication Unlicensed Licensed	37
II. Fibrinogen-Fibrin Conversion
Synthetic peptide Gly-His-Arg-Pro activates fibrin monomers Miha Furlan, Chrlstoph Rupp and Eugene A. Beck Requires Authentication Unlicensed Licensed	49
Fibrinopeptide characterization and kinetics of release in animal fibrinogens as analysed by highperformance liquid chromatography John Lucas, Maria Kehl and Agnes Henschen Requires Authentication Unlicensed Licensed	59
III. Interaction with Divalent Cations
The topography of fibrinogen fragment D David W. Britton, Angela Apap-Bologna, Jan S. Lawrie and Graham D. Kemp Requires Authentication Unlicensed Licensed	73
Calcium binding to fibrinogen investigated by rate of dialysis Graham D. Kemp, Joan Ross and David W. Britton Requires Authentication Unlicensed Licensed	85
Calcium-binding sites and anticlotting properties of human fibrinogen and fibrin(ogen) fragments Willem Nieuwenhuizen, Frits Haverkate, Anton Vermond, Marijke Voskuilen and Alfons C.M. van der Drift Requires Authentication Unlicensed Licensed	97
Binding of fibrinogen and degradation products to chelated zinc M. F. Scully and V. V. Kakkar Requires Authentication Unlicensed Licensed	111
IV. Abnormal Fibrinogens
Genetically abnormal fibrinogens - some current characterisation strategies Agnes Henschen, Maria Kehl, Christopher Southan, Friedrich Lottspeich and Dionysios Georgopoulos Requires Authentication Unlicensed Licensed	125
Two-dimensional electrophoretic characterization (iso-dalt) of fibrinogen and fibrin subunit chains from four different genetic dysfibrinogen variants Frank Brosstad, Brita Teige, Bjørnar Olaisen, Karl Gravem, Hans Charistian Godal and Helge Stormorken Requires Authentication Unlicensed Licensed	145
The molecular abnormality of fibrinogen Manchester D.A. Lane, H. Ireland, C. Southan, M. Kehl and A. Henschen Requires Authentication Unlicensed Licensed	155
Functional characterisation and protein chemical analysis of two new cases of dysfibrinogenemia, London III & IV Chris Southan, David A. Lane and Agnes Henschen Requires Authentication Unlicensed Licensed	167
Genetically abnormal fibrinogens releasing abnormal fibrinopeptides as characterised by high-performance liquid chromatography Maria Kehl, Friedrich Lottspeich and Agnes Henschen Requires Authentication Unlicensed Licensed	183
Sialic acid and sialyltransferase in the pathogenesis of acquired dysfibrinogenaemia J.L. Francis and D.J. Armstrong Requires Authentication Unlicensed Licensed	195
V. Fibrinogen Derived Products in vitro and in vivo
Comparative studies on F-CB3 related antigen, fibrinogen degradation products, soluble fibrin monomer complexes and fibrinogen in patients with renal carcinoma R. Gollwitzer, R. Hafter, W. Streifinger and H. Graeff Requires Authentication Unlicensed Licensed	209
Characterization of crosslinked high molecular weight fibrin derivatives from in vitro and in vivo (ascitic fluid) material Reimar Hafter, Edeltraud Klaubert and Henner Graeff Requires Authentication Unlicensed Licensed	215
Immunochemical differentiation of fibrinogen, fragment D or E, and cross-linked fibrin degradation products using monoclonal antibodies J. Soria, C. Soria, C. Boucheix, M. Mirshahi, J.Y. Perrot, A. Bernadou and M. Samama Requires Authentication Unlicensed Licensed	227
Purification and properties of early (X-like) and late (D-like) fibrinogen fragments, produced by leukocyte elastase L. Sterrenberg, A. Blonk, G.J. van Liempt, J. Hermans and W. Nieuwenhuizen Requires Authentication Unlicensed Licensed	235
Formation of fibrin degradation products from a non-anticoagulated whole blood clot J. Koopman and F. Haverkate Requires Authentication Unlicensed Licensed	255
VI. Biosynthesis and Clearance
Changes of synthesis of fibrinogen polypeptide and albumin mRNAs in rat liver after turpentine injection and after partial hepatectomy or laparotomy Hans M.G. Princen, Gerard C.M. Selten, Willem Nieuwenhuizen and Sing Hiem Yap Requires Authentication Unlicensed Licensed	263
Role of kidney in eliminating low molecular weight fibrinogen derivatives from the circulation D.A. Lane, J. Markwick, E. Thompson and H. Ireland Requires Authentication Unlicensed Licensed	279
Clearance of I¹²⁵ fibrinogen and I¹³¹soluble fibrin in normals and in fibrinaemic patients: a pilot study Frank Brosstad, Peter Kierulf, Tor Hamborg, Bjørn Holm and Hans Christian Godal Requires Authentication Unlicensed Licensed	287
Clearance of homologous fibrin monomers and fibrin(ogen) degradation products in the rat Willem Nieuwenhuizen, Jef J. Emeis and Anton Vermond Requires Authentication Unlicensed Licensed	291
VII. Other Physiological Aspects of Fibrinogen
Evidence for Specific sites in fibrin(ogen) that stimulate tissue activator catalyzed plasminogen activation J.H. Verheijen, W. Nieuwenhuizen, E. Mullaart, G. Chang and A. Vermond Requires Authentication Unlicensed Licensed	305
Vasoactive Peptides Released From The ßß-Chain On Degradation Of Human Fibrin(Ogen) By Plasmin Or Elastase Tom Saldeen Requires Authentication Unlicensed Licensed	315
Interactions between fibrin and fibronectin. No effect of fibronectin on the plasma solubility of fibrin monomers B. Holm and F. Brosstad Requires Authentication Unlicensed Licensed	323
Interactions between fibronectin and soluble fibrin - no effect of fibrin monomers upon the formation of the heparin precipitable fraction of plasma B. Holm, F. Brosstad and H.C. Godal Requires Authentication Unlicensed Licensed	329
Author Index Requires Authentication Unlicensed Licensed	337
Subject Index Requires Authentication Unlicensed Licensed	339
Backmatter Requires Authentication Unlicensed Licensed	344

Publishing information

Pages and Images/Illustrations in book

eBook published on:

June 17, 2019

eBook ISBN:

9783110850642

Hardcover published on:

March 1, 1983

Hardcover ISBN:

9783110089868

Edition:

Reprint 2019

Pages and Images/Illustrations in book

Front matter:

16

Main content:

343

Other:

Num. figs.

https://doi.org/10.1515/9783110850642

eBook ISBN: 9783110850642

Hardcover ISBN: 9783110089868

Safety & product resources

Manufacturer information:
Walter de Gruyter GmbH
Genthiner Straße 13
10785 Berlin
productsafety@degruyterbrill.com

[2] Structure, functional aspects, metabolism

Overview

Topics

Table of contents

Bibliographic data